Weekly paclitaxel combined with monthly carboplatin in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study.
Fiche publication
Date publication
mai 2006
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr DEBIEUVRE Didier
Tous les auteurs :
Pujol JL, Milleron B, Molinier O, Quoix E, Depierre A, Breton JL, Gervais R, Debieuvre D, Hominal S, Namouni F, Tonelli D
Lien Pubmed
Résumé
We designed this phase II trial to evaluate the efficacy and safety of weekly paclitaxel in combination with monthly carboplatin as first-line treatment in elderly patients with advanced non-small cell lung cancer (NSCLC).
Mots clés
Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, therapeutic use, Carboplatin, administration & dosage, Carcinoma, Non-Small-Cell Lung, drug therapy, Female, Humans, Lung Neoplasms, drug therapy, Male, Paclitaxel, administration & dosage, Quality of Life
Référence
J Thorac Oncol. 2006 May;1(4):328-34